DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,798 filers reported holding DANAHER CORPORATION in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,121,842 | +5.4% | 12,583 | +2.0% | 0.33% | +3.4% |
Q2 2023 | $2,963,258 | -3.2% | 12,333 | +1.6% | 0.32% | -7.5% |
Q1 2023 | $3,061,530 | -7.4% | 12,134 | -2.5% | 0.35% | -15.5% |
Q4 2022 | $3,306,263 | +4.6% | 12,445 | +1.8% | 0.41% | -14.3% |
Q3 2022 | $3,162,000 | +2.0% | 12,229 | +0.1% | 0.48% | -0.6% |
Q2 2022 | $3,100,000 | -10.9% | 12,214 | +2.5% | 0.48% | -6.2% |
Q1 2022 | $3,479,000 | -2.5% | 11,918 | +10.0% | 0.52% | -3.9% |
Q4 2021 | $3,568,000 | +9.9% | 10,839 | +1.7% | 0.54% | -5.0% |
Q3 2021 | $3,248,000 | +23.4% | 10,660 | +8.8% | 0.56% | +11.0% |
Q2 2021 | $2,632,000 | +18.3% | 9,801 | -0.7% | 0.51% | +11.1% |
Q1 2021 | $2,225,000 | +7.0% | 9,866 | +5.5% | 0.46% | -6.9% |
Q4 2020 | $2,080,000 | -5.8% | 9,356 | -8.6% | 0.49% | -21.8% |
Q3 2020 | $2,207,000 | +4.3% | 10,241 | -14.4% | 0.63% | +2.4% |
Q2 2020 | $2,116,000 | +0.0% | 11,964 | -21.7% | 0.61% | -20.4% |
Q1 2020 | $2,115,000 | -7.3% | 15,283 | +2.8% | 0.77% | +7.1% |
Q4 2019 | $2,281,000 | – | 14,865 | – | 0.72% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |